Table 4 Comparison of the decrease magnitude between the 2 subgroups
Group1 | Group2 | P-value | ||
|---|---|---|---|---|
Lung | ||||
V5 (%) | −4.8 ± 8.0 | −9.1 ± 4.5 | 0.212 | |
V20 (%) | −12.3 ± 13.3 | −11.6 ± 6.8 | 0.473 | |
MLD (%) | −14.6 ± 11.4 | −17.2 ± 7.9 | 0.678 | |
Heart | ||||
V30 (%) | −16.5 ± 36.4 | −34.4 ± 53.4 | 0.212 | |
Mean (%) | −15.8 ± 17.0 | −28.4 ± 36.5 | 0.212 | |
Max (%) | −2.3 ± 1.9 | −10.5 ± 18.1 | 0.473 | |
Esophagus | ||||
V40 (%) | −10.8 ± 17.2 | −9.7 ± 17.8 | 0.85 | |
V50 (%) | −14.8 ± 21.1 | −10.2 ± 22.6 | 0.385 | |
V60 (%) | −28.0 ± 48.9 | −21.9 ± 24.8 | 0.791 | |
AV60 (%) | −28.0 ± 48.9 | −21.9 ± 24.8 | 0.791 | |
Mean (%) | −11.0 ± 12.3 | −7.6 ± 14.8 | 0.385 | |
Max (%) | −0.6 ± 4.7 | 0.1 ± 3.3 | 0.734 |